omniture
维亚生物科技

Latest News

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate ...

2025-09-29 17:00 863

Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights

SHANGHAI, Sept. 2, 2025 /PRNewswire/ -- Peptides have recently emerged at the forefront of therapeu...

2025-09-02 17:52 1257

Viva Biotech Successfully Held The 3rd Annual Partnership Summit

SHANGHAI, June 23, 2022 /PRNewswire/ -- June 16th-20th, 2022 (Beijing time), Viva Biotech 2022 Part...

2022-06-23 20:30 2792

Portfolio Highlights: Clinical and Financing Updates of Anji, AIxplorerBio, Domain, VivaVision, ArrePath, QurAlis and Apeiron

SHANGHAI, May 26, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovato...

2022-05-26 23:53 3664

Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%

Financial Highlights of the year ended December 31, 2021: * Revenue amounted to RMB2,104.1 millio...

2022-03-29 01:01 3148

Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%

Financial Highlights of the year ended December 31, 2021: * Revenue amounted to RMB2,104.1 millio...

2022-03-29 00:49 2904

Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests

SHANGHAI, March 18, 2022 /PRNewswire/ -- At present, COVID-19 is still in pandemic status around th...

2022-03-18 17:47 2526